Nav: Home

News from Dec. 23, 2014, Annals of Internal Medicine

December 22, 2014

1. Blood pressure drugs likely to prevent stroke and death in patients with mild hypertension

Pharmacologic blood pressure reduction may prevent major cardiovascular events and death in patients with mild, or stage 1 hypertension (systolic blood pressure of 140 to 159 mm Hg and/or diastolic blood pressure of 90 to 99 mm Hg), according to a systematic review published in Annals of Internal Medicine. Having elevated blood pressure is the leading cause of premature death globally and the number of persons with clinically abnormal blood pressure is increasing. Most of these patients have mild hypertension and no overt cardiovascular disease and the effects of pharmacologic blood pressure reduction in this group are unclear. Researchers conducted a systematic review of published evidence to determine whether pharmacologic blood pressure reduction prevents cardiovascular events and deaths in persons with mild hypertension. They found that blood pressure-lowering therapy tended to lead to reductions in stroke, cardiovascular deaths, and total deaths.

Note: The URL for this story will be live when embargo lifts. For a PDF, please contact Megan Hanks. To interview Dr. Johan Sundström, please contact Maria Åslund at or +46 18 611 95 44.

2. Task force reviews evidence to update blood pressure screening recommendations

Ambulatory monitoring may improve the diagnostic accuracy of office screening

Repeated measurements taken outside of a medical setting by ambulatory blood pressure monitoring may improve the diagnostic accuracy of blood pressure screening conducted in a clinical setting, according to an evidence review published in Annals of Internal Medicine. Nearly one in three U.S. adults has high blood pressure, the leading risk factor for premature death. Previous evidence reviews have shown that treatment of adults with high blood pressure can reduce cardiovascular disease events. Researchers for the U.S. Preventive Services Task Force (USPSTF) reviewed published studies to update a systematic review on the benefits and harms of screening for high blood pressure in adults. The researchers also summarized evidence on rescreening intervals and diagnostic and predictive accuracy of different blood pressure screening methods for cardiovascular events. Ambulatory blood pressure monitoring should be considered a reference standard for confirming elevated office blood pressure screening results to avoid misdiagnosis and overtreatment, unless immediate treatment is required. In addition, the review suggests that certain high-risk people should be screened more often than those without risk factors, and that there is a need for improving the accuracy of blood pressure measurement in the clinic. A draft recommendation statement will be posted for public comment at the USPSTF web site at when the embargo lifts.

Note: The URL will be live when the embargo lifts. For a PDF, please contact Megan Hanks. To interview the author of the evidence review, please contact Mary Sawyers at To interview a member of the Task Force, please contact Ana Fullmer or Nicole Raisch at

American College of Physicians

Related Blood Pressure Articles:

Do you really have high blood pressure?
A study by researchers at the University of Montreal Hospital Research Centre (CRCHUM) shows that more than half of family doctors in Canada are still using manual devices to measure blood pressure, a dated technology that often leads to misdiagnosis.
Why do we develop high blood pressure?
Abnormally high blood pressure, or hypertension, may be related to changes in brain activity and blood flow early in life.
For some, high blood pressure associated with better survival
Patients with both type 2 diabetes and acute heart failure face a significantly lower risk of death but a higher risk of heart failure-related hospitalizations if they had high systolic blood pressure on discharge from the hospital compared to those with normal blood pressure, according to a study scheduled for presentation at the American College of Cardiology's 66th Annual Scientific Session.
$9.4 million grant helps scientists explore how cell death from high blood pressure fuels even higher pressure
It's been known for decades that a bacterial infection can raise your blood pressure short term, but now scientists are putting together the pieces of how our own dying cells can fuel chronically high, destructive pressure.
Blood pressure diet improves gout blood marker
A diet rich in fruits, vegetables, low-fat dairy and reduced in fats and saturated fats (the DASH diet), designed decades ago to reduce high blood pressure, also appears to significantly lower uric acid, the causative agent of gout.
New tool to improve blood pressure measurement
Oxford University researchers have developed a prediction model that uses three separate blood pressure readings taken in a single consultation and basic patient characteristics to give an adjusted blood pressure reading that is significantly more accurate than existing models for identifying hypertension.
Blood vessels sprout under pressure
It is blood pressure that drives the opening of small capillaries during angiogenesis.
Better blood pressure control -- by mobile phone
An interactive web system with the help of your mobile phone can be an effective tool for better blood pressure control.
Time to reassess blood-pressure goals
High blood pressure or hypertension is a major health problem that affects more than 70 million people in the US, and over one billion worldwide.
With help from pharmacists, better blood pressure costs $22
A pharmacist-physician collaboration in primary-care offices effectively and inexpensively improved patients' high blood pressure.

Related Blood Pressure Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...